For this, we analyzed a breast cancer tissue microarray (TMA) that comprised three immunohistochemistry (IHC) subtypes: ER-positive (ER+, PR+/−, and HER2−), HER2-positive (HER2+, ER+/−, and PR+/−), and TNBC. Here, ERBB2 is linked to breast carcinoma.